PHILADELPHIA, PA — The biotech firm Cabaletta Bio, Inc. (Nasdaq: CABA) is poised to take center stage at two high-profile investor conferences this March. The company, renowned for its pioneering work in engineered T cell therapies, is set to share insights into its groundbreaking research and development.
The first event on the calendar is the TD Cowen 44th Annual Health Care Conference in Boston, where CEO Steven Nichtberger, M.D., will participate in a fireside chat on March 5, 2024, at 12:50 p.m. ET. Additional members of the management team will also be available for one-on-one meetings, providing investors a unique opportunity to delve deeper into the company’s strategies and future plans.
Following the Boston conference, Cabaletta Bio will head to Miami for the Jefferies Biotech on the Bay Summit on March 12, 2024. Once again, management team members will be available for individual meetings, offering further opportunities for dialogue with industry insiders.
Those unable to attend these events in person can still gain valuable insights from the company. A live webcast of the presentation at the TD Cowen conference will be available on the news and events section of Cabaletta Bio’s website, with replays accessible for 30 days.
Cabaletta Bio has made significant strides in the field of autoimmune disease treatment. Its CABA™ platform houses two key strategies: CARTA, with lead product candidate CABA-201 being evaluated in the RESET™ clinical trials for systemic lupus erythematosus, myositis, systemic sclerosis, and generalized myasthenia gravis, and CAART, which includes clinical-stage candidates DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis.
The company’s participation in these influential industry events underscores its commitment to developing potentially curative therapies that offer deep and durable responses for patients with a wide range of autoimmune diseases. As Cabaletta Bio continues its trailblazing work, the medical community and industry watchers eagerly anticipate the insights and advancements that will emerge from these conferences.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.